Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantificationSuzanne M Dufault, Geraint R Davies, Elin M Svensson, et al.International Journal of Antimicrobial Agents|December 9, 2024
Analysis of time-to-positivity data in tuberculosis treatment studies: Identifying a new limit of quantificationSuzanne M Dufault, Geraint R Davies, Elin M Svensson, et al.Open Forum Infectious Diseases|August 1, 2020
Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic AnalysisFrank Kloprogge, Henry C Mwandumba, Gertrude Banda, et al.BMC Infectious Diseases|April 13, 2017
TST positivity in household contacts of tuberculosis patients: a case-contact study in MalawiJonas Hector, Suzanne T Anderson, Gertrude Banda, et al.Tuberculosis (Edinburgh, Scotland)|June 9, 2015
Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosisDavid T Mzinza, Derek J Sloan, Kondwani C Jambo, et al.Nature Medicine|November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.Nature Medicine|November 7, 2018
A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2015
Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary TuberculosisDerek J Sloan, Henry C Mwandumba, Natalie J Garton, et al.Antimicrobial Agents and Chemotherapy|May 3, 2017
Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary TuberculosisDerek J Sloan, Andrew D McCallum, Alessandro Schipani, et al.Journal of Clinical Microbiology|May 11, 2012
Optimizing outpatient serial sputum colony counting for studies of tuberculosis treatment in resource-poor settingsDerek J Sloan, Elizabeth L Corbett, Anthony E Butterworth, et al.Pageof 4